Innate Pharma gets US FDA clearance to begin phase 1 study of Nectin-4 ADC, IPH4502 to treat solid tumours: Marseille, France Tuesday, September 24, 2024, 16:00 Hrs [IST] Innate P ...
Some results have been hidden because they may be inaccessible to you